Loading...
GSK posted a robust quarter with £7.99 billion in revenue and £1.89 billion in net income. EPS rose to 46.5p as operating profit margins improved, supported by growth in Specialty Medicines and pipeline progress.
Revenue reached £7.99 billion, up from £7.88 billion last year
EPS rose to 46.5p from 43.4p, driven by improved margins
Net income totaled £1.89 billion in the quarter
Cash generated from operations grew to £3.73 billion
GSK expects to deliver toward the top end of FY2025 guidance, driven by strong Specialty Medicines performance, robust pipeline momentum, and improved operational efficiency.
Visualization of income flow from segment revenue to net income